HRP950174B1 - Method and composition for the prevention of lyme disease - Google Patents

Method and composition for the prevention of lyme disease

Info

Publication number
HRP950174B1
HRP950174B1 HR950174A HRP950174A HRP950174B1 HR P950174 B1 HRP950174 B1 HR P950174B1 HR 950174 A HR950174 A HR 950174A HR P950174 A HRP950174 A HR P950174A HR P950174 B1 HRP950174 B1 HR P950174B1
Authority
HR
Croatia
Prior art keywords
prevention
composition
lyme disease
burgdorferi
physiologically
Prior art date
Application number
HR950174A
Other languages
English (en)
Inventor
Ian Livey
Friedrich Dorner
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP950174(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from YU68592A external-priority patent/YU68592A/sh
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of HRP950174A2 publication Critical patent/HRP950174A2/hr
Publication of HRP950174B1 publication Critical patent/HRP950174B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR950174A 1991-07-11 1995-03-30 Method and composition for the prevention of lyme disease HRP950174B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72724591A 1991-07-11 1991-07-11
US82416192A 1992-01-22 1992-01-22
US07/903,580 US6221363B1 (en) 1991-07-11 1992-06-25 Vaccine for the prevention of lyme disease
YU68592A YU68592A (sh) 1991-07-11 1992-07-09 Kompozicija za sprečavanje lajmske bolesti i postupak za dobijanje

Publications (2)

Publication Number Publication Date
HRP950174A2 HRP950174A2 (en) 1997-08-31
HRP950174B1 true HRP950174B1 (en) 2001-08-31

Family

ID=27419096

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950174A HRP950174B1 (en) 1991-07-11 1995-03-30 Method and composition for the prevention of lyme disease

Country Status (17)

Country Link
US (2) US6221363B1 (xx)
EP (1) EP0522560B2 (xx)
JP (1) JP2611095B2 (xx)
AT (1) ATE198489T1 (xx)
AU (1) AU660178B2 (xx)
CA (1) CA2073486C (xx)
CZ (1) CZ280743B6 (xx)
DE (1) DE69231619T3 (xx)
DK (1) DK0522560T4 (xx)
ES (1) ES2154633T3 (xx)
FI (1) FI107334B (xx)
HR (1) HRP950174B1 (xx)
HU (1) HU219772B (xx)
MX (1) MX9204078A (xx)
NO (1) NO304546B1 (xx)
SI (1) SI9200143B (xx)
SK (1) SK217292A3 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872550B1 (en) * 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6303129B1 (en) * 1992-07-28 2001-10-16 Rx Technologies Production of borrelia burgdorferi vaccine, product produced thereby and method of use
PL178775B1 (pl) * 1993-04-29 2000-06-30 Baxter Ag Kompozycja immunogenna, rekombinacyjne sekwencje DNA, rekombinacyjny wektor ekspresyjny, transformowana komórka gospodarza i antygen OspC
US6248562B1 (en) 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
PT757556E (pt) 1994-04-11 2006-10-31 Wyeth Corp Bacterina borrelia burgdorferi
US6087097A (en) * 1994-05-12 2000-07-11 Mayo Foundation For Medical Education And Research PCR detection of Borrelia burgdorferi
ZA964896B (en) * 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
CN1285608C (zh) * 1995-09-22 2006-11-22 康诺特实验室有限公司 副流感病毒糖蛋白和疫苗
WO1997015600A1 (en) * 1995-10-26 1997-05-01 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
US6045804A (en) * 1996-03-07 2000-04-04 Mayo Foundation For Medical Educational Research Method for detecting B. burgdorferi infection
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
US6969520B2 (en) * 1997-10-20 2005-11-29 Acambis Inc. Active immunization against clostridium difficile disease
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
EP1173577A2 (en) * 1999-04-21 2002-01-23 Boston Medical Center Corporation Prevention, diagnosis and treatment of lyme disease
PT1194559E (pt) * 1999-06-18 2007-01-31 Brook Biotechnologies Inc Grupos de borrelia burgdorferi e borrelia afzelii que causam a doença de lyme em seres humanos
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
US8277852B2 (en) * 2002-01-25 2012-10-02 Akzo Nobel Surface Chemistry Llc Bioactive botanical cosmetic compositions and processes for their production
US7442391B2 (en) * 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
ES2652603T3 (es) 2004-01-12 2018-02-05 Isp Investments Llc Composiciones bioactivas de plantas de Theacea y procedimientos para su producción y uso
EP1983247A1 (en) 2006-01-19 2008-10-22 Toyo Seikan Kaisya, Ltd. Coupler and fuel cartridge for fuel cell
EP2077856B1 (en) * 2006-11-03 2015-08-12 Intervet International BV Canine lyme disease vaccine
ATE496935T1 (de) 2007-02-22 2011-02-15 Baxter Int Verfahren zur aufreinigung hydrophober proteine
JP2011518338A (ja) * 2008-04-22 2011-06-23 リサーチ ファンデーション オブ ステート ユニバーシティ オブ ニューヨーク ボレリア・ブルグドルフェリ（ｂｏｒｒｅｌｉａｂｕｒｇｄｏｒｆｅｒｉ）の細胞エンベロープタンパク質のアレイ
CN102791727A (zh) * 2009-11-17 2012-11-21 爱贝斯股份有限公司 用于检测莱姆病抗体的肽和方法
DK3549949T5 (da) 2011-04-22 2024-09-02 Wyeth Llc Sammensætninger vedrørende et mutant Clostridium-difficile-toksin og fremgangsmåder dertil
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
KR102451333B1 (ko) * 2018-10-22 2022-10-06 주식회사 엘지화학 마이크로비드 및 그 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
US4601903A (en) * 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US4888276A (en) 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
US4721617A (en) 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
US5192540A (en) * 1988-04-19 1993-03-09 American Cyanamid Company Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
DE3818013A1 (de) 1988-05-27 1989-11-30 Henkel Kgaa Gewebeweichmachungsmittel
IT1223777B (it) * 1988-08-18 1990-09-29 Gevipi Ag Rubinetto a due uscite con inversore a depressione
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
DE3942728C1 (en) 1989-12-22 1991-05-23 Mikrogen Molekularbiologische Entwicklungs-Gmbh, 8000 Muenchen, De New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
CA2072008C (en) * 1989-12-22 2003-01-28 Renate Fuchs Immunologically active proteins from borrelia burgdorferi, related test kits which contain these proteins and are suitable for detecting antibodies in test fluids, and the use of these proteins as vaccines against infections caused by borrelia strains
DE69122240T2 (de) 1990-03-05 1997-02-13 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Antigen-wirkende proteine von borrelia burgdorferi
EP1016416A3 (en) * 1990-07-06 2002-10-23 Wyeth Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy

Also Published As

Publication number Publication date
SK279250B6 (sk) 1998-08-05
AU660178B2 (en) 1995-06-15
US6221363B1 (en) 2001-04-24
FI923175A (fi) 1993-01-12
EP0522560A3 (en) 1994-05-11
DE69231619T3 (de) 2007-07-12
ES2154633T3 (es) 2001-04-16
JP2611095B2 (ja) 1997-05-21
EP0522560B2 (en) 2006-12-20
AU1934992A (en) 1993-01-14
EP0522560B1 (en) 2001-01-03
FI923175A0 (fi) 1992-07-09
NO922746D0 (no) 1992-07-10
CA2073486A1 (en) 1993-01-12
EP0522560A2 (en) 1993-01-13
US5530103A (en) 1996-06-25
ATE198489T1 (de) 2001-01-15
DE69231619T2 (de) 2001-05-31
SK217292A3 (en) 1998-08-05
HRP950174A2 (en) 1997-08-31
SI9200143B (en) 2001-06-30
CZ217292A3 (en) 1993-01-13
HUT66525A (en) 1994-12-28
NO304546B1 (no) 1999-01-11
DE69231619D1 (de) 2001-02-08
CZ280743B6 (cs) 1996-04-17
JPH072696A (ja) 1995-01-06
HU219772B (hu) 2001-07-30
NO922746L (no) 1993-01-12
DK0522560T3 (da) 2001-03-05
HU9202289D0 (en) 1992-10-28
DK0522560T4 (da) 2007-04-10
SI9200143A (en) 1993-03-31
FI107334B (fi) 2001-07-13
MX9204078A (es) 1993-04-01
CA2073486C (en) 2002-07-02

Similar Documents

Publication Publication Date Title
HUT66525A (en) Method and composition for the prevention of lyme disease
AU2187992A (en) Composition and method for disease treatment
AU8377791A (en) Apparatus for applying two-part surgical fasteners
AU663647B2 (en) Apparatus for applying two-part surgical fasteners
AU1012092A (en) Method and apparatus for arthroscopic knee surgery
AU8398491A (en) Surgical containment apparatus
EP0537571A3 (en) Apparatus for applying surgical fasteners
EP0656188A3 (en) Surgical device for applying surgical clips.
AU2536492A (en) Apparatus for applying surgical fasteners
DE69430749D1 (de) Wiedergewinnbares, abgeschirmtes röntgentherapuetisches implantat
EP0499260A3 (en) Procedure for hydrolyzing keratin
AU4241093A (en) Compositions and methods for vaccination against coronaviruses
AU5818194A (en) Device for preventing thrombus circulation in vascular ducts
EP0514850A3 (en) Mis type semiconductor device and method for producing such semiconductor device
IL94477A0 (en) Device for performing surgical implants
HU9600067D0 (en) Pharmaceutical composition for immunomodulating and adjuvant treatment
AU2968892A (en) Vaccines based on modified type 1 bovine herpesviruses
IL109758A0 (en) Pharmaceutical compositions for treating ulcer
EP0415812A3 (en) Ramp for orthopaedic chair
ZA914464B (en) Method and compositions for treating hiv-type 1 infection
AU2510192A (en) Tissue augmentation device and method
EP0614364A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFECTIONS USING OPTICALLY PURE (S) -LOMEFLOXACIN.
DE69534740D1 (en) Analoge des thymosin alpha 1
PT91947A (pt) Colchao ortopedico
HK1070295A1 (en) Opiod formulations for treating pain

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: BAXTER AKTIENGESELLSCHAFT, AT

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030107

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20030710